Opportunity Overview
The purpose of Amendment 3 to Solicitation 75A50326R00007 is to extend the proposal submission deadline from 21 September 2026 to 22 September 2026 at 1:00 PM EST and provide the Government's responses to RFP Questions. Refer to revised Attachment 3 which incorporates column E. The Government has a need to procure a variety of FDA approved pharmaceuticals.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | ASPR/ORM-SNS |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| NAICS | 325412 |
| PSC | 6505 |
| Published | September 19, 2026 |
| Procurement stage | Active solicitation |
| Closed | September 22, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 10, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Browse Similar Open Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.